# Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.

> **NCT04522960** · NA · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 60 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIAGNOSTIC_TEST:** MEG+hdEEG+MRI

## Key facts

- **NCT ID:** NCT04522960
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-20
- **Primary completion:** 2023-07
- **Final completion:** 2023-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04522960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04522960, "Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04522960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*